Description

Moxifloxacin Decarboxy Analog CAS NO 1322062-57-6 is a key pharmaceutical intermediate and reference standard used in the development and quality control of active pharmaceutical ingredients (APIs). This compound is critical for ensuring the purity, safety, and efficacy of final drug products, particularly within the fluoroquinolone antibiotic class. It is primarily required by pharmaceutical manufacturers, analytical laboratories, and research institutions engaged in synthesis, method validation, and regulatory compliance.

Application

• Pharmaceutical Intermediate: A crucial building block in the synthesis of advanced fluoroquinolone antibiotics and related compounds.
• Analytical Reference Standard: Used for method development, validation, and quality control testing (e.g., HPLC, LC-MS) to quantify impurities and assay active ingredients.
• Process Research & Development (R&D): Serves as a standard for optimizing synthetic routes and scaling up production processes in API manufacturing.
• Regulatory Compliance & Documentation: Essential for preparing impurity profiles and regulatory submission dossiers (e.g., for FDA, EMA) to demonstrate product quality.
• Metabolite Studies: Used in pharmacological and toxicological research to study drug metabolism pathways.

Basic Information

Product Name	Moxifloxacin Decarboxy Analog
CAS No.	1322062-57-6
Molecular Formula	C21H24FN3O3
Molecular Weight	385.43 g/mol
Synonyms	1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid decarboxy analog; Moxifloxacin Decarboxylated Impurity; Moxifloxacin Impurity D (Decarboxy); Avelox Decarboxy Analog; BAY 12-8039 Decarboxy Derivative; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline
EINECS	Contact for details

Quality Control

Our Moxifloxacin Decarboxy Analog is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the high standards required for pharmaceutical applications. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment to support your quality assurance and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is light-sensitive and should be handled and stored accordingly to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.